Riber S.A (ALRIB) - Total Liabilities
Based on the latest financial reports, Riber S.A (ALRIB) has total liabilities worth €27.29 Million EUR (≈ $31.91 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Riber S.A - Total Liabilities Trend (2005–2024)
This chart illustrates how Riber S.A's total liabilities have evolved over time, based on quarterly financial data. See ALRIB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Riber S.A Competitors by Total Liabilities
The table below lists competitors of Riber S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA
|
USA | $4.30 Million |
|
KB No4 SPAC
KQ:205500
|
Korea | ₩43.90 Billion |
|
Surge Battery Metals Inc
V:NILI
|
Canada | CA$590.00K |
|
Alterity Therapeutics Ltd
AU:ATH
|
Australia | AU$2.65 Million |
|
Tamil Nadu Newsprint & Papers Limited
NSE:TNPL
|
India | Rs38.94 Billion |
|
Mdevice
KQ:226590
|
Korea | ₩68.93 Billion |
|
Union Bankshares Inc
NASDAQ:UNB
|
USA | $1.50 Billion |
|
Intertek Group PLC
LSE:ITRK
|
UK | GBX2.63 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down Riber S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Riber S.A worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.10 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Riber S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Riber S.A (2005–2024)
The table below shows the annual total liabilities of Riber S.A from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €26.29 Million ≈ $30.73 Million |
-3.00% |
| 2023-12-31 | €27.10 Million ≈ $31.68 Million |
-3.34% |
| 2022-12-31 | €28.04 Million ≈ $32.78 Million |
+30.38% |
| 2021-12-31 | €21.50 Million ≈ $25.14 Million |
+0.55% |
| 2020-12-31 | €21.39 Million ≈ $25.00 Million |
+12.61% |
| 2019-12-31 | €18.99 Million ≈ $22.20 Million |
+2.22% |
| 2018-12-31 | €18.58 Million ≈ $21.72 Million |
+5.02% |
| 2017-12-31 | €17.69 Million ≈ $20.68 Million |
+62.68% |
| 2016-12-31 | €10.87 Million ≈ $12.71 Million |
+6.63% |
| 2015-12-31 | €10.20 Million ≈ $11.92 Million |
+12.07% |
| 2014-12-31 | €9.10 Million ≈ $10.64 Million |
-3.16% |
| 2013-12-31 | €9.40 Million ≈ $10.99 Million |
-8.70% |
| 2012-12-31 | €10.29 Million ≈ $12.03 Million |
-28.71% |
| 2011-12-31 | €14.44 Million ≈ $16.88 Million |
+12.35% |
| 2010-12-31 | €12.85 Million ≈ $15.03 Million |
+63.39% |
| 2009-12-31 | €7.87 Million ≈ $9.20 Million |
-24.48% |
| 2008-12-31 | €10.42 Million ≈ $12.18 Million |
-22.91% |
| 2007-12-31 | €13.51 Million ≈ $15.80 Million |
-8.81% |
| 2006-12-31 | €14.82 Million ≈ $17.32 Million |
-30.11% |
| 2005-12-31 | €21.20 Million ≈ $24.78 Million |
-- |
About Riber S.A
Riber S.A. provides molecular beam epitaxy (MBE) products and related services for the compound semiconductor research and industrial field. The company offers MBE systems, such as research and pilot production systems, real-time curvature measurement products, and laser passivation tools; and MBE sources, including effusion cells, gas and valved sources, resistive cells, and valved cracker sourc… Read more